(Q73141414)

English

The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy

scientific article published on 01 November 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

familial hypercholesterolemia

1 reference

based on heuristic

inferred from title

author name string

A Yamamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Harada-Shiba

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Kawaguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Oi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Kubo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Sakai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Y Mikami

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Imai

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Ito

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Kato

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Endo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

I Sato

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Y Suzuki

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Hori

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

153

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

89-98

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

How effective is drug therapy in heterozygous familial hypercholesterolemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Plasmapheresis for prevention and regression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Apheresis technology for prevention and regression of atherosclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

LDL-apheresis; potential procedure for prevention and regression of atheromatous vascular lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Regression of carotid plaques during low density lipoprotein cholesterol elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Siblings with normal LDL receptor activity and severe hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Therapeutic effects of ML-236B in primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Automated immunoturbidimetric analysis of six plasma apolipoproteins: correlation with radial immunodiffusion assays

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: reference values, and age- and sex-related differences

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Receptor-Mediated Control of Cholesterol Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Effects of probucol on homozygous cases of familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900373-7

7 January 2021

Identifiers

10.1016/S0021-9150(00)00373-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11058703%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73141414&oldid=1756390903"